Voloshyna I - Search Results

1

CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.

Reiss AB, Miyawaki N, Moon J, Kasselman LJ, Voloshyna I, D'Avino R Jr, De Leon J. Reiss AB, et al. Among authors: voloshyna i. Atherosclerosis. 2018 Nov;278:49-59. doi: 10.1016/j.atherosclerosis.2018.08.046. Epub 2018 Aug 30. Atherosclerosis. 2018. PMID: 30253289 Review.

2

Cholesterol Metabolism in CKD.

Reiss AB, Voloshyna I, De Leon J, Miyawaki N, Mattana J. Reiss AB, et al. Among authors: voloshyna i. Am J Kidney Dis. 2015 Dec;66(6):1071-82. doi: 10.1053/j.ajkd.2015.06.028. Epub 2015 Sep 1. Am J Kidney Dis. 2015. PMID: 26337134 Free PMC article. Review.

3

The ABC transporters in lipid flux and atherosclerosis.

Voloshyna I, Reiss AB. Voloshyna I, et al. Prog Lipid Res. 2011 Jul;50(3):213-24. doi: 10.1016/j.plipres.2011.02.001. Epub 2011 Feb 23. Prog Lipid Res. 2011. PMID: 21352852 Review.

4

Regulation of cerebral cholesterol metabolism in Alzheimer disease.

Reiss AB, Voloshyna I. Reiss AB, et al. Among authors: voloshyna i. J Investig Med. 2012 Mar;60(3):576-82. doi: 10.2310/JIM.0b013e318246d973. J Investig Med. 2012. PMID: 22367100 Free PMC article. Review.

5

Resveratrol in cholesterol metabolism and atherosclerosis.

Voloshyna I, Hussaini SM, Reiss AB. Voloshyna I, et al. J Med Food. 2012 Sep;15(9):763-73. doi: 10.1089/jmf.2012.0025. Epub 2012 Aug 2. J Med Food. 2012. PMID: 22856383 Review.

6

Atherosclerosis and interferon-γ: new insights and therapeutic targets.

Voloshyna I, Littlefield MJ, Reiss AB. Voloshyna I, et al. Trends Cardiovasc Med. 2014 Jan;24(1):45-51. doi: 10.1016/j.tcm.2013.06.003. Epub 2013 Aug 2. Trends Cardiovasc Med. 2014. PMID: 23916809 Free PMC article. Review.

7

Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A.

Voloshyna I, Teboul I, Kasselman LJ, Salama M, Carsons SE, DeLeon J, Mattana J, Miyawaki N, Reiss AB. Voloshyna I, et al. Inflamm Res. 2019 Sep;68(9):787-799. doi: 10.1007/s00011-019-01262-8. Epub 2019 Jun 21. Inflamm Res. 2019. PMID: 31227843

8

Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy.

Reiss AB, Arain HA, Kasselman LJ, Renna HA, Zhen J, Voloshyna I, DeLeon J, Carsons SE, Petri M. Reiss AB, et al. Among authors: voloshyna i. Medicina (Kaunas). 2019 Aug 21;55(9):514. doi: 10.3390/medicina55090514. Medicina (Kaunas). 2019. PMID: 31438615 Free PMC article.

9

The role of interferon-γ in cardiovascular disease: an update.

Elyasi A, Voloshyna I, Ahmed S, Kasselman LJ, Behbodikhah J, De Leon J, Reiss AB. Elyasi A, et al. Among authors: voloshyna i. Inflamm Res. 2020 Oct;69(10):975-988. doi: 10.1007/s00011-020-01382-6. Epub 2020 Jul 22. Inflamm Res. 2020. PMID: 32699989 Review.

10

Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model.

Kasselman LJ, Renna HA, Voloshyna I, Pinkhasov A, Gomolin IH, Teboul I, De Leon J, Carsons SE, Reiss AB. Kasselman LJ, et al. Among authors: voloshyna i. J Tradit Complement Med. 2022 Feb 1;12(5):447-454. doi: 10.1016/j.jtcme.2022.01.006. eCollection 2022 Sep. J Tradit Complement Med. 2022. PMID: 36081818 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters